Approval · Notice of Compliance 32093 · 2023
METVIX: Notice of Compliance 32093
Issued November 15, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32093
- Date
- November 15, 2023
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug substance manufacturer. Change in the manufacturing process for the drug substance. Change in the primary container closure system for the drug substance.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METVIX | Not yet assigned | — |
Medicinal ingredients
- METHYL AMINOLEVULINATE HYDROCHLORIDE 168 MG per G